CTIS2023-506019-16-01进行中（未招募）1 期
aHyC-TNBC
Celica d.o.o.0 个研究点目标入组 50 人开始时间: 2024年4月27日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
/ACerebral venous thrombosisEUCTR2010-020302-15-PTIMM - Instituto de Medicina Molecular164
进行中（未招募）
1 期
A Phase 1 Study to Investigate the Effect of Food on the Bioavailability of a Single Cytisinicline 3 mg Tablet and Evaluation of the Pharmacokinetics of Multiple 3 mg Doses (Three Times Daily) in Healthy Adult Smokerso medical conditionCTIS2023-504260-42-00Achieve Life Sciences Inc.30
进行中（未招募）
1 期
A Phase I Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 against Crimean Congo Hemorrhagic Fever (CCHF-NP-1)Crimean Congo Hemorrhagic FeverMedDRA version: 20.1Level: PTClassification code: 10010685Term: Congo-Crimean haemorrhagic fever Class: 100000004862CTIS2023-508556-18-00Karolinska Institutet15
进行中（未招募）
不适用
Administration of a single dose or of three doses of AM-101to patients with Tinnitus (Ringing in the Ears) and comparision of both doses.Acute inner ear tinnitus following acute acustic trauma, acute otitis media, middle ear surgery, or inner ear barotraumaMedDRA version: 14.1Level: PTClassification code 10043882Term: TinnitusSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2011-005384-24-DEAuris Medical AG72
进行中（未招募）
1 期
Administration of a single dose or of three doses of AM-101to patients with Tinnitus (Ringing in the Ears) and comparision of both doses.EUCTR2011-005384-24-BEAuris Medical AG72